Clincosm LogoSign in Get a demo

melanoma

Showing NaN - NaN of 175
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Uveal Melanoma, Melanoma, Metastatic Uveal Melanoma Trial in Harrison, New York (Lifileucel (LN-144))

Recruiting
  • Uveal Melanoma
  • +3 more
  • Lifileucel (LN-144)
  • Harrison, New York
  • +1 more
Nov 8, 2022

Renal Cell Cancer, Melanoma, Non-Small-Cell Lung Cancer Trial in Duarte, Louisville, New York (PF-07263689, Sasanlimab)

Active, not recruiting
  • Renal Cell Cancer
  • +9 more
  • PF-07263689
  • Sasanlimab
  • Duarte, California
  • +5 more
Nov 8, 2022

Real Time Decision-Making About Ultraviolet Radiation Protection

Active, not recruiting
  • Melanoma
  • screening questionnaire
  • New York, New York
    Memorial Sloan Kettering Cancer Center
Nov 7, 2022

Melanoma Trial in Worldwide (Pembrolizumab, Placebo)

Active, not recruiting
Has Results
  • Melanoma
  • Pembrolizumab
  • Placebo
  • Tucson, Arizona
  • +158 more
Oct 31, 2022

Melanoma, Ovarian Cancer, Sarcoma Trial in Italy, Portugal, United States (IGIMRT using a single dose of 24 Gy, IGIMRT 27 Gy in

Active, not recruiting
  • Melanoma
  • +6 more
  • IGIMRT using a single dose of 24 Gy
  • IGIMRT 27 Gy in 3 fractions
  • San Francisco, California
  • +3 more
Nov 1, 2022

Solid Tumor, Colorectal Cancer, Cholangiocarcinoma Trial in France, United States (TRK-950, Irinotecan, Leucovorin)

Recruiting
  • Solid Tumor
  • +11 more
  • TRK-950
  • +14 more
  • Scottsdale, Arizona
  • +13 more
Oct 2, 2022

Breast Cancer, Colorectal Cancer, Ovarian Cancer Trial in United States (ATRC-101, Pembrolizumab, Pegylated liposomal

Recruiting
  • Breast Cancer
  • +15 more
  • ATRC-101
  • +2 more
  • Phoenix, Arizona
  • +10 more
Sep 28, 2022

Melanoma, NSCLC, Breast Cancer Trial in United States (CDX-1140, CDX-301, Pembrolizumab)

Completed
  • Melanoma
  • +25 more
  • Scottsdale, Arizona
  • +10 more
Sep 27, 2022

Melanoma Trial in United States (TLPLDC, Placebo)

Completed
  • Melanoma
  • Birmingham, Alabama
  • +17 more
Sep 15, 2022

Advanced Cancer, Angiosarcoma, Colorectal Cancer Without Liver Metastases Trial in United States (Botensilimab, Balstilimab)

Recruiting
  • Advanced Cancer
  • +7 more
  • Scottsdale, Arizona
  • +14 more
Sep 15, 2022

Melanoma Trial in New York (DC Vaccine, Montanide Vaccine, Poly-ICLC)

Completed
  • Melanoma
  • DC Vaccine
  • +2 more
  • New York, New York
  • +1 more
Sep 13, 2022

NSCLC, Melanoma Trial in Worldwide (LXH254, LTT462, Trametinib)

Active, not recruiting
  • Non-Small Cell Lung Cancer
  • Melanoma
  • San Diego, California
  • +31 more
Sep 12, 2022

Melanoma, Ocular Melanoma Trial in United States (Nivolumab, Ipilimumab)

Active, not recruiting
  • Melanoma
  • Ocular Melanoma
  • San Francisco, California
  • +5 more
Aug 31, 2022

Breast Cancer, Cholangiocarcinoma, Colorectal Cancer Trial in Worldwide (Entrectinib)

Recruiting
  • Breast Cancer
  • +15 more
  • Goodyear, Arizona
  • +146 more
Aug 24, 2022

Melanoma Trial in Worldwide (Belvarafenib, Cobimetinib, Atezolizumab)

Recruiting
  • Melanoma
  • Orange, California
  • +23 more
Aug 24, 2022

Melanoma Trial in Australia, United States (mRNA-4157, Pembrolizumab)

Active, not recruiting
  • Melanoma
  • mRNA-4157
  • Pembrolizumab
  • Tucson, Arizona
  • +21 more
Aug 23, 2022

Advanced Cancer, Melanoma, NSCLC Trial in Worldwide (BMS-986205, Nivolumab, Ipilimumab)

Completed
  • Advanced Cancer
  • +2 more
  • Tucson, Arizona
  • +46 more
Aug 18, 2022

Advanced Malignant Solid Tumor, Bladder Carcinoma, Breast Carcinoma Trial in Guam, Puerto Rico, United States (drug, procedure,

Recruiting
  • Advanced Malignant Solid Neoplasm
  • +49 more
  • Birmingham, Alabama
  • +1429 more
Aug 17, 2022

Melanoma Trial in Worldwide (Pembrolizumab, Pembrolizumab/Quavonlimab, Lenvatinib)

Recruiting
  • Melanoma
  • Pembrolizumab
  • +2 more
  • Los Angeles, California
  • +28 more
Aug 12, 2022

Melanoma Trial in New York (Nivolumab, Ipilimumab)

Completed
Has Results
  • Melanoma
  • Nivolumab
  • Ipilimumab
  • New York, New York
    Laura and Isaac Perlmutter Cancer Center
Aug 11, 2022

Head Neck Cancer, Head and Neck Tumor, Thoracic Tumor Trial in United States (IM@Home, Enhanced usual care)

Recruiting
  • Head and Neck Cancer
  • +6 more
  • IM@Home
  • Enhanced usual care
  • Basking Ridge, New Jersey
  • +6 more
Aug 9, 2022

Implementation National_001

Recruiting
  • Melanoma
    • Tampa, Florida
    • +8 more
    Aug 8, 2022

    Melanoma, Unresectable Melanoma Trial in Los Angeles, Boston, New York (Sarilumab, Ipilimumab Injection, Nivolumab/Relatlimab)

    Not yet recruiting
    • Melanoma
    • Unresectable Melanoma
    • Los Angeles, California
    • +3 more
    Aug 4, 2022

    Melanoma, Advanced Melanoma, Metastatic Melanoma Trial in United States (CMP-001, Nivolumab)

    Active, not recruiting
    • Melanoma
    • +3 more
    • Phoenix, Arizona
    • +24 more
    Aug 1, 2022

    Tumors, Colorectal Tumors, Melanoma Trial in United States (Alectinib)

    Terminated
    • Neoplasms
    • +27 more
    • Culver City, California
    • +28 more
    Jul 25, 2022